ACON Buprenorphine (BUP) Drug Test Devices


(40 Tests)

ACON BUP One Step Buprenorphine Test Device. One step urine test device is a lateral flow chromatographic immunoassay for the detection of Buprenorphine in human urine at a cut off concentration of 10 ng/mL. FDA Cleared and CLIA Classified as Moderately Complex. (FDA 510K#: K060466)

ACON Cassette Pipette Test

  • Collect the specimen with the pipette
  • Add 3 drops to the well
  • Read the results in as little as 3 minutes
  • Ideal for low-volume donations

Single Panel Test Device available individually for the following drugs:

  • *(AMP) Amphetamines DAM-102
  • (BAR) Barbiturate DBA-102
  • (BZO) Benzo DBZ-102
  • (BUP) Buprenorphine BUP-101
  • *(COC) Cocaine DCO-102
  • (MDMA) Ecstasy DMD-102
  • *(mAMP) Methamp DMA-102
  • (MTD) Methadone DMT-102
  • *(PCP) PCP DPC-102
  • (PPX) Propoxyphene DPP-102
  • *(OPI) Opiates2000 DOP-102
  • (OXY) Oxycodone DOX-102
  • (MOP) Opiates300 DMO-102
  • *(THC) Marijuana DTH-102
  • (TCA) Tricyclic DTC-102

*The following drugs test cassettes are available CLIAwaived


CPT Code*: 80305 - Drug test(s), presumptive, any number of drug classes, qualitative; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipstick, cups, cards, cartridges) includes sample validation when performed, per date of service (maps to 80300 or G0477).

National Average Reimbursement 2019: $12.60

*All CPT codes are supplied for information purposes only and represent no statement; promise or guarantee by CLIAwaived Inc. that these codes will be appropriate or that reimbursement will be made. It is the responsibility of the service provider to confirm the appropriate coding required by their local Medicare carriers, fiscal intermediaries and commercial payors.

© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.